PRESS RELEASE published on 05/06/2024 at 23:25, 2 years 5 months ago Jolt Health To Acquire HCQ Transdermal Patch Technology Jolt Health Inc. acquires intellectual property for transdermal delivery tech of HCQ & CQ to address underserved lupus, rheumatoid arthritis, and malaria markets worth $6B by 2027* Jolt Health Inc. Hydroxychloroquine Transdermal Delivery Technology Chloroquine FDA Approved
BRIEF published on 03/27/2024 at 21:55, 2 years 7 months ago Jolt Health Inc. annonce la clôture du financement Financement Placement Privé Remboursement De Dette Jolt Santé Inc. Fonds De Roulement
BRIEF published on 03/27/2024 at 21:55, 2 years 7 months ago Jolt Health Inc. Announces Closing of Financing Private Placement Working Capital Financing Debt Repayment Jolt Health Inc
PRESS RELEASE published on 03/27/2024 at 21:50, 2 years 7 months ago Jolt Health Inc. Announces Closing of Financing Jolt Health Inc. closes non-brokered private placement of 50,000,000 units at $0.01 per unit for gross proceeds of $500,000. Proceeds to be used for working capital and debt repayment. Insider participation and warrant details disclosed Private Placement Working Capital Non-brokered Common Share Jolt Health Inc.
BRIEF published on 03/08/2024 at 13:05, 2 years 7 months ago Jolt Health Inc. annonce des expansions stratégiques et des changements au conseil d'administration Santé Et Bien-être Médicaments Jolt Santé Inc. Développement De Médicaments IA Financement Par Placement Privé
BRIEF published on 03/08/2024 at 13:05, 2 years 7 months ago Jolt Health Inc. Announces Strategic Expansions and Board Changes Pharmaceuticals Private Placement Financing Health And Wellness Jolt Health Inc. AI Drug Development
PRESS RELEASE published on 03/08/2024 at 13:00, 2 years 7 months ago Jolt Health Inc., Letter to the Shareholders Jolt Health Inc. focuses on health & wellness, AI drug dev., pharma sectors. Company adds Mr. Cody Corrubia to the board & announces private placement financing. Read the letter to shareholders for details Private Placement Financing Health And Wellness Jolt Health Inc. AI Drug Development Pharmaceutical Sectors
PRESS RELEASE published on 02/27/2023 at 23:10, 3 years 8 months ago Love Pharma Inc. Announces Share Consolidation
Published on 11/05/2026 at 15:20, 4 hours 45 minutes ago MicroVision and LAKE FUSION Technologies Sign Multi-Year Strategic Partnership Agreement for IRIS(TM) Lidar Sensors
Published on 11/05/2026 at 14:31, 5 hours 34 minutes ago First Breach Close-Quarters Strike (CQS) Drone Successfully Completes Full Mission Profile
Published on 11/05/2026 at 14:25, 5 hours 40 minutes ago Polaris Renewable Energy Announces Q3 2026 Results
Published on 11/05/2026 at 14:20, 5 hours 45 minutes ago Polaris Renewable Energy Declares Quarterly Dividend
Published on 11/05/2026 at 14:15, 5 hours 50 minutes ago Loar Holdings Inc. Reports Q3 2026 Record Results and Upward Revision to 2026 Outlook and Full Year 2027 Outlook
Published on 11/05/2026 at 19:45, 19 minutes ago Stabilus SE fulfills forecast for fiscal 2026 and adjusts 2030 medium-term targets
Published on 11/05/2026 at 19:41, 24 minutes ago EQS-Adhoc: Stabilus SE – Around €67 million in non-cash impairments reduce EBIT for FY2026; Preliminary Q4 FY2026 figures: Revenue and adjusted EBIT exceed market expectations, while adjusted free cash flow fall
Published on 11/05/2026 at 18:09, 1 hour 56 minutes ago EQS-Adhoc: JOST Werke SE: JOST raises outlook for fiscal year 2026
Published on 11/05/2026 at 18:00, 2 hours 5 minutes ago 2CRSi SA: Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 octobre 2026
Published on 11/05/2026 at 18:21, 1 hour 43 minutes ago Total number of voting rights and shares making up the share capital at October 31, 2026
